<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=412980&amp;fmt=gif">
LSX-Blog.png

Something Powerful

Tell The Reader More

The headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.

Remember:

  • Bullets are great
  • For spelling out benefits and
  • Turning visitors into leads.

BioMedical Bonding: A paradigm shift in bone resto...

Biomedical Bonding AB is a Swedish Medtech company that develops new orthop...

Read More

50 NORDIC life science start-ups to look out for i...

A few weeks ago we released '50 Nordic life science startups to look out fo...

Read More

OnDosis: Improving treatment by Integrating oral m...

Pharmaceutical innovation has accelerated, but the way of dosing oral medic...

Read More

50 NORDIC life science start-ups to look out for i...

LSX is pleased to announce the first in a series of eBooks, showcasing 50 l...

Read More

Eli Lilly v Genentech: the question of SPCs based ...

Mr Justice Arnold recently handed down two judgements in the dispute betwee...

Read More

Is the healthcare market one of the last markets t...

The latest LSX Investor Perception Survey offers an interesting snapshot in...

Read More

Promising New Drug Nivolumab Tested on Mesotheliom...

Originally developed for and tested on a number of common cancers, the drug...

Read More

The ABCs of Supplementary Protection Certificates

Patents are used to protect technical inventions and prevent competitors fr...

Read More

Who wants to live to 100?

Tonight Show Host Johnny Carson once asked his 99 year old guest, comedian ...

Read More

Medical devices: Investment trends, challenges and...

In the current climate there are several major challenges or trends in inve...

Read More

How to pitch to a life science VC investor

Pitching a venture capital fund is not an easy exercise for many entreprene...

Read More

Bridging the investment gap between drug discovery...

Established in 2012, the CRT Pioneer Fund (CPF), managed by Sixth Element C...

Read More

Add Your Response